Evidence map›Paper›PMID 40734637›Full record

ArticleEnvironmental microbiology reports2025

Isolation of Halophilic and Halotolerant Bacterial Strains, Screening for Bioactive Compounds and Characterisation of Metabolites Produced by Pseudoalteromonas sp. ASV78.

Maia Azpiazu-Muniozguren, Elena Valgañón-Pérez, Minerva García-Martínez, Alba Rodriguez-Paniagua, H Poppy Clark, Carlos Justicia, Jesús Martín, Mercedes de la Cruz Moreno, Fernando Reyes, Lorena Laorden and 2 more

Abstract read
In one paragraph

Article in Environmental microbiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maia Azpiazu-MuniozgurenMikroIker Research Group, Immunology, Microbiology and Parasitology Department, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Elena Valgañón-PérezMikroIker Research Group, Immunology, Microbiology and Parasitology Department, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Minerva García-MartínezMikroIker Research Group, Immunology, Microbiology and Parasitology Department, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Alba Rodriguez-PaniaguaDepartment of Organic Chemistry I, Faculty of Pharmacy and Lascaray Research Center, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
H Poppy ClarkDepartment of Chemistry, Marine Biodiscovery Centre, University of Aberdeen, Aberdeen, UK.ORCID https://orcid.org/0000-0002-1667-9922
Carlos JusticiaFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla Granada, Spain.
Jesús MartínFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla Granada, Spain.
Mercedes de la Cruz MorenoFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla Granada, Spain.
Fernando ReyesFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla Granada, Spain.ORCID https://orcid.org/0000-0003-1607-5106
Lorena LaordenMikroIker Research Group, Immunology, Microbiology and Parasitology Department, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Irati Martinez-MalaxetxebarriaMikroIker Research Group, Immunology, Microbiology and Parasitology Department, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.ORCID https://orcid.org/0000-0002-6576-6707
Ilargi Martinez-BallesterosMikroIker Research Group, Immunology, Microbiology and Parasitology Department, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.ORCID https://orcid.org/0000-0002-8867-1487

Funding

Añana Salt Valley FoundationBasque Government PIBA23/06University of the Basque Country UPV/EHU GIU21/021
6 · The paper itself

Abstract

Halophilic and halotolerant microorganisms are an important source of natural products. In this study, a collection of 150 bacterial isolates from a continental saltern (Añana Salt Valley, Spain) was obtained, identified and screened for the production of antimicrobial and/or surface-active compounds. The identification of the isolates showed the predominance of the Pseudomonadota phylum with 106 isolates (70.7%) classified under this taxon. Subsequent bioassays identified 20 antimicrobial producers and 14 isolates with the ability to both reduce surface tension and emulsify. One of them, namely, ASV78 was characterised in detail. Pseudoalteromonas sp. ASV78 showed simultaneous production of pentabromopseudilin and bromophene, with antibacterial activity, as well as glycolipids with the ability to reduce surface tension and glycoproteins with effective emulsifying properties. The low concentration of pentabromopseudilin (MIC values ranging from 0.02 to 0.04 μg/mL) at which it is effective against S. aureus ATCC 29213 was noteworthy, as was the compound's activity against other clinically relevant Gram-negative and Gram-positive bacteria. The presence of biosynthetic gene clusters (BGCs) in the genome of strain ASV78 that are not included among the known BGCs suggests the possibility that they encode unknown molecules. The applicability of the compounds synthesised by Pseudoalteromonas sp. ASV78 and the potential of the isolate collection require further investigation.

Indexed as

PseudoalteromonasAnti-Bacterial AgentsBiological ProductsGlycolipidsMicrobial Sensitivity TestsPhylogenySpainStaphylococcus aureusSurface-Active AgentsAnti-Bacterial AgentsBiological ProductsGlycolipidsSurface-Active Agentsantimicrobialbiosynthetic gene clustershalophilic bacteriasurface‐active compounds

Identifiers

PMID40734637
PMCPMC12308153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.